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Autoimmune diseases are more prevalent in females than in 
males. This disparity also exists in autoimmune disease models (1) 
and appears to be partly hormone dependent. Sex steroids amelio-
rate experimental autoimmune encephalomyelitis (EAE)3, an an-
imal model of multiple sclerosis (2– 4), but the mechanism(s) by 
which they alter the disease are unclear. Because immune cells ex-
press estrogen and androgen receptors (5, 6), sex hormones may act 
directly on Ag-specific T cells to alter their functions. Some studies 
suggest that sex steroids induce immune deviation from a Th1 to a 
Th2 phenotype (2– 4, 7). 
A subset of CD4+ cells called CD4+CD25+ regulatory T (Treg) 
cells that expresses Forkhead box P3 (Fox P3) can control auto-
immune responses (8 –10). Estrogen modulates the expression of 
Fox P3 mRNA and middle-aged male mice with EAE have di-
minished Treg cell activity (11, 12), but it is not known whether 
Treg cell functions are affected by gender. Immunization with 
myelin proteolipid protein (PLP) 139– 151 results in EAE in male 
and female SJL (I-As) mice with comparable severity, but only 
female mice show chronic relapsing- remitting disease (13, 14). 
In contrast, B10.S mice (H-25 congenic with SJL) are relatively 
resistant to PLP 139–151-induced EAE (15), but it is not known 
whether gender affects resistance. Using IAs tetramers for PLP 
139–151, we found more myelin PLP-specific Treg cells in the na-
ive periphery of female B10.S mice than in SJL mice (15). Deple-
tion of Treg cells in vivo in female B10.S mice predisposed them 
moderately to EAE. 
We report here that although male B10.S mice have fewer PLP 
139–151 tetramer+ CD4 cells than female mice, depletion of Treg 
cells in vivo makes them more susceptible to PLP 139–151-in-
duced EAE with increased inflammatory cytokine production and 
more severe clinical and histological disease than nondepleted 
mice. Although male and female B10.S mice have comparable 
Treg cell functions, effector cells expand more in male than in fe-
male mice in response to TCR-mediated stimulation. These results 
indicate that Treg cells partly contribute to gender differences in 
EAE susceptibility. 
Materials and Methods 
Mice 
B10.S (B10.S-H2s/Sg) wild-type (wt) mice 4–8 wk old were 
obtained from McLaughlin Research Institute. B10.S/Sg-
Tg(TcrPLP)1858Hpw mice (referred to as 5B6 transgenic (tg) B10.S 
mice) transgenic for the PLP139–151- specific TCR 5B6 were generated 
and maintained as described previously (16). 
Peptide synthesis and immunization procedures 
PLP 139–151 (HSLGKWLGHPDKF) and neuraminidase (NASE) 
101–120 (EALVRQGLAKVAYVYKPNNT) were synthesized on 
Fmoc chemistry and used for immunizations as described previ-
ously (15). 
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Abstract 
Female B10.S mice are highly resistant to proteolipid protein (PLP) 139–151-induced experimental autoimmune encephalomyeli-
tis (EAE) and depletion of PLP 139–151- reactive CD4+CD25+regulatory T (Treg) cells can slightly increase their EAE susceptibil-
ity. Although male B10.S mice are moderately susceptible to EAE, we report that depletion of Treg cells in male B10.S mice before 
immunization with PLP 139–151 renders them highly susceptible to severe EAE with more CNS neutrophil infiltrates than nonde-
pleted controls. Increased susceptibility is associated with an enhanced PLP 139–151-specific T cell response and greater produc-
tion of IFN-γ, IL-6, and IL-17. Male CD4+CD25+ effector cells depleted of Treg cells proliferate to a greater degree than those from 
females in response to either anti-CD3 or PLP 139–151. These data suggest that because of their capacity to regulate potent autoag-
gressive effector cells, Treg cells partly contribute to the resistance to autoimmunity in the male mice.  
Abbreviations: EAE, experimental autoimmune encephalomyelitis; Treg, regulatory T; PLP, proteolipid protein; wt, wild type; 
tg, transgenic; TMEV, Theiler’s murine encephalomyelitis virus; 7-AAD, 7-aminoactinomycin D; PMN, polymorphonuclear 
leukocyte
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Proliferation assays 
To assess inhibitory effects of Treg cells, PLP 139–151-specific 5B6 
tg T cells were fractionated into CD4+CD25+ and CD4+CD25- cells by 
magnetic separation (Miltenyi Biotec). They were plated at a density 
of 1 x 106 cells/ml in the presence of APCs and PLP 139–151 (20 μg/
ml) for 2 days in complete DMEM. After pulsing with 1 mCi of [3H]
thymidine (1 Ci = 37 GBq) for 16 h, proliferation was measured as 
counts per minute. CD3+ T cells enriched by negative selection (R&D 
Systems) from immunized B10.S wt mice were stimulated with PLP 
139–151 in the presence of APCs. Response of CD4+CD25- T cells to 
anti-CD3 (1 μg/ml, clone, 145-2C11; BD Pharmingen) was tested with 
CD11c+ cells as APCs. 
Flow cytometry 
To study cellular subsets in lymph nodes, various mAbs procured 
from BD Pharmingen. After staining, cells were analyzed by flow cy-
tometry (FACSCalibur; BD Biosciences); data were analyzed using 
FlowJo software (Tree Star). 
IAs tetramer staining 
Frequencies of Ag-specific T cells were determined by flow cytom-
etry using IAs/PLP 139–151 and Theiler’s murine encephalomyelitis 
virus (TMEV) 70–86 tetramers (negative control) as described previ-
ously (15). Four-color analysis included anti-CD25/FITC (clone, 7D4), 
IAs tetramers (PE), 7-aminoactinomycinD( 7-AAD), and anti-CD4-allo-
phycocyanin (clone, RM4-5). Percentages of tetramer+ cells in the live 
(7-AAD-) CD4+population were determined. 
Cytokine analysis 
CD3+ T cells were enriched from anti-CD25- and control Ig-treated 
B10.S mice 10 days after immunization with PLP 139–151. They were 
stimulated with APCs loaded with PLP 139–151 (50 μg/ml) for 4–6 
days. Supernatants on day 2 were tested for cytokines by ELISAs, and 
frequencies of cytokinesecreting cells were determined on day 4 by in-
tracellular staining, as described previously (15). 
Real-time (TaqMan) RT-PCR 
Total RNA was extracted from CD4+CD25- and CD4+CD2+ cells 
from a group of B10.S mice followed by treatment with DNase 1 
(RNeasy kit; Qiagen). cDNA was synthesized using TaqMan RT re-
agents (Applied Biosystems). Fox P3 and GAPDH mRNA was mea-
sured by PCR in separate tubes in duplicates using probes labeled 
with FAM and VIC and with TAMRA as a quencher using TaqMan 
universal mix and the ABI Prism 7700 sequence detection system (Ap-
plied Biosystems). Primers and probe for GAPDH were purchased 
(Applied Biosystems). Fox P3 sequences were as described previ-
ously (17). A comparative threshold cycle (CT) was used to determine 
mRNA expression of Fox P3 and GAPDH relative to no-template con-
trol (calibrator). CT value was normalized for each sample using the 
formula: ΔCT = CT (Fox P3) - CT (GAPDH), and the relative expression of 
Fox P3 was then calculated using the formula 2-CT. 
Histopathology 
Following induction of EAE, the mice were monitored for clini-
cal signs of disease for 4 wk and scored as described previously (13). 
Mice were killed when their score reached ≥4 or when they began to 
recover. Brains and spinal cords were fixed in 10% phosphate-buff-
ered formalin. Histologic disease was evaluated as previously de-
scribed (13) and polymorphonuclear leukocyte (PMN) infiltration as 
described in Table I legend. 
Statistics 
Student’s t test was used to determine significance of data except 
for rank correlations between inflammatory foci and PMN scores, 
which were determined by Wilcoxon signed rank test. A value of p ≤ 
0.05 was considered significant. 
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Results and Discussion 
We report here that Treg cells partly contribute to gender dif-
ferences in susceptibility to EAE. We previously showed that PLP 
139–151-reactive Treg cells exist in the naive periphery of EAE-re-
sistant B10.S female mice and that depletion of these in vivo before 
immunization with PLP 139–151 resulted in expansion of IFN-γ-
producing cells and induction of EAE in ~30% of mice (15). Because 
autoimmune diseases are more common in females than males, we 
hypothesized that there may  be gender differences in the function 
of the naturally occurring CD4+CD25+ Treg cell subset. 
When we depleted Treg cells in vivo by administration of 
anti- CD25 Ab in male B10.S mice before immunization, 85% of 
the mice (12 of 14) developed moderate to severe EAE, whereas 
only 3 of 12 control mice (25%) developed mild EAE, i.e., loss of 
tail tonicity (p ≤ 0.001) (Table I). In agreement with our previous 
results (15), a small number of female B10.S mice (three of nine, 
33%) depleted of Treg cells but no control Abtreated mice devel-
oped disease, suggesting that genetic resistance to EAE in female 
B10.S mice does not lie entirely in the Treg population. In female 
B10.S mice, multiple factors may contribute to EAE resistance, i.e., 
Ag-specific defects in Th1 cytokine secretion and IL12-Rb2 expres-
sion (18, 19), a tendency to produce elevated amounts of Th2 cy-
tokines (20), APCs (16) and the presence of a high proportion of 
Treg cells that react with PLP 139–151 tetramers in their naive pe-
riphery (15). Once males develop EAE following anti-CD25 treat-
ment, there were no other clinical differences between males and 
females. Histologic disease in anti-CD25 Ab-treated male mice 
was significantly greater than in the controls (p ≤ 0.0003) (Table I), 
and there were more PMNs in CNS infiltrates (p ≤ 0.0004) (Table 
I, Figure 1). The histologic disease in males was also more severe 
than in anti-CD25-treated females (mean total inflammatory foci 
= 124.9 vs 44.8) (p ≤ 0.05). The disease severity in females was en-
hanced when compared with control mice but inflammatory foci 
contained fewer neutrophils (Table I, Figure 1b).  
To determine the mechanisms for greater incidence and sever-
ity of EAE in Treg-depleted male B10.S mice, we tested whether 
there are any differences in Treg cell function between male and 
female B10.S mice in vitro. 
We first determined that male B10.S mice have a higher per-
centage of CD3+ cells in their lymph nodes than age-matched fe-
male B10.S mice, but the percentage of Treg cells is lower in males 
(Table II). We then confirmed that Treg cells in male and female 
B10.S mice are equally effective in inhibiting expansion of effec-
tor cells using anti-CD3 as a stimulus (data not shown). FoxP3 
mRNA, a marker for Treg cells, was also expressed in comparable 
amounts (Figure 2a). Therefore, we could identify no major differ-
ences in Treg populations between male and female B10S mice. 
We next tested whether Treg cells from male and female B10.S 
mice have any defect in their suppressive function in response 
to self-Ags using TCR tg mice specific to PLP 139– 151 (16). We 
found that Treg cells from male and female tg B10.S mice did not 
proliferate to PLP 139–151, whereas male and female effector cells 
responded equally well to PLP 139– 151. Treg cells inhibited the 
proliferative response of effector cells but there were differences; 
the inhibition of CD4+CD25- cells mediated by Treg cells in female 
B10.S mice was maintained even at low ratios of regulatory: effec-
tor cells. However, in male mice as ratios of Treg cells to effectors 
were lowered, the effector cells expanded to a greater extent (Fig-
ure 2b). This suggests either that Treg cells from female mice are 
more efficient in their suppressive function than those in males or 
that the effector cells in males are capable of responding to auto-
antigens  more vigorously than those in females. We quantified 
Figure 1. Effect of anti-CD25 treatment on CNS inflammatory infil-
trates in PLP 139–151-immunized male and female B10.S mice. a, An 
inflammatory focus in an anti-CD25-treated male mouse with EAE 
contains a predominance of neutrophils intermixed with mononu-
clear cells (PMN score = 3+; see legend to Table I). b, Typical mononu-
clear infiltrates in an anti-CD25- treated female mouse (PMN score = 
0). c, A small subpial mononuclear cell infiltrate in a control Ig-treated 
male mouse. d, No inflammatory cell infiltrates in a control Ig-treated 
female mouse. Each panel is from the spinal cord with a spinal nerve 
root on the left side of the field. Luxol fast blue-H&E stain. Original 
magnification, ×240. Bar in a = 25 μm.  
Figure 2. PLP 139–151-specific 
Treg cells are functional in both 
male and female B10.S mice. a, 
Fox P3 and GAPDH mRNA ex-
pression in Treg and CD4+CD25- 
cells. Each bar represents rel-
ative Fox P3 mRNA mean ± 
SEM values. n =5 (four to five 
mice per sample). b, Treg and 
CD4+CD25- cells isolated from 
PLP 139–151-specific tg B10.S 
mice of either sex were stimu-
lated with PLP 139–151 together 
at indicated ratios or separately 
and proliferation was measured 
as described in Materials and 
Methods. A representative experi-
ment is shown. 
Table II. Lymphocyte subsets in male and female B10.S micea
         Marker                                Male                                   Female
CD3b  51.06 ± 0.99  44.68 ± 1.84
Gate: CD3+ cells
CD4  49.36 ± 0.77  50.52 ± 1.33
CD8  42.82 ± 0.43  40.52 ± 1.43
CD25c  7.70 ± 0.26  9.71 ± 0.29
Gate: CD3- cells
CD11b  3.77 ± 0.55  3.23 ± 0.26
CD11c  0.97 ± 0.08  0.97 ± 0.05
B220  77.98 ± 1.50           80.6 ± 0.61
a. Lymph node cells from male and female B10.S mice were stained 
with the indicated markers. The percentages of individual subsets 
were then determined by flow cytometry. n = 5/group
b. p ≤ 0.007
c. p ≤ 0.00047
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the precursor frequency of PLP 139–151 tetramer+ cells in male 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
mice to be 0.04% of CD4 cells (8 in 20,000). By contrast, the precur-
sor frequency in female B10.S mice is 40 in 20,000 CD4 cells (15). 
We did not observe any significant shift in PLP 139– 151 tetramer 
reactivity in effector vs Treg cells, as previously reported in female 
B10.S mice (15) (data not shown). Therefore, the higher incidence 
and greater severity of EAE in male B10.S mice are unlikely to be 
due to an increased frequency or function of PLP 139–151-specific 
Treg cells. 
We next compared T cell proliferation to PLP 139–151 be-
tween anti-CD25 and rat IgG-treated male mice. The PLP 
139–151-specific responses, but not NASE responses, were sig-
nificantly higher in the anti-CD25 Ab-treated than in the con-
trol group (Figure 3a). Consistent with this, percentages of PLP 
139–151 tetramer+CD4 cells were increased by ~3-fold more in 
the anti-CD25 Ab-treated males compared with controls (Figure 
3b). This response was specific because there was negligible reac-
tivity to TMEV 70–86 tetramers. These data suggest that the ex-
pansion of PLP 139–151-reactive cells in mice depleted of Treg 
cells contributed to the more severe disease. This expansion ap-
peared to have resulted from the loss of regulation mediated by 
Treg cells, which can prevent the expansion of effector cells in an 
Ag nonspecific manner (21). 
Previously, male SJL mice immunized with myelin basic pro-
tein or PLP were found to produce IL-4 and IL-10, while females 
produced more IFN-γ (2, 22). We tested whether a similar bias 
exists in immunized male B10.S mice, with or without Treg cell 
depletion. By ELISA, the production of both IL-2 (p ≤ 0.01) and 
IFN-γ (p ≤ 0.006) was significantly elevated, with a marginal in-
crease in IL-17 production (p ≤ 0.08) on day 2 in the cultures de-
rived from CD25+ cell-depleted male mice compared with con-
trols (Figure 3c). As previously noted in female B10.S mice (15), 
IL-10 secretion was reduced in the anti-CD25 Ab-treated group 
(p ≤ 0.02), suggesting that Treg cells may directly or indirectly 
regulate IL-10 production. However, by intracellular stain-
ing, the frequencies of cells secreting all of the cytokines tested 
(IL-2, IL-4, IL-6, IL-10, IL-17, and IFN-γ) were elevated in anti-
CD25-treated male mice (Figure 3c). Among proinflammatory 
cytokines, IFN-γ-secreting cells were present at a higher fre-
quency (3.09 vs 1.35) followed by IL-17 (1.09 vs 0.41) and IL-6 
(0.5 vs 0.21) in the anti-CD25-treated vs control mice. The num-
ber of TNF-α-secreting cells did not vary between groups (data 
not shown). Recently, it was reported that   IL-23-dependent 
production of inflammatory cytokines (IL-17, IL-17F, IL-6, and 
TNF-α) is essential for the development of CNS inflammation 
(23). In anti-CD25 Ab-treated mice, the numbers of cells that se-
crete IFN-γ, IL-6, and IL-17 was increased, implying that Treg 
cells regulate the expression of these cytokines. In the absence 
of Treg cells, the effector cells producing inflammatory cytokines 
may expand resulting in altered chemokines and increased pro-
portions of PMNs in inflammatory foci (24). 
Figure 4. Ag-specific, 
CD4+CD25- effector cells 
from male B10.S mice ex-
pand more vigorously than 
those derived from female 
mice. a, CD4+CD25- cells iso-
lated by magnetic separa-
tion from male and female 
B10.S mice were stimulated 
with anti-CD3 Ab (1 μg/ml) 
and CD11+c cells as APCs, 
and proliferation was mea-
sured as described in Materi-
als and Methods. A represen-
tative experiment of three is 
shown. b, CD3+ cells were 
enriched from male and fe-
male B10.S mice pretreated 
with anti-CD25 or IgG Ab 
and immunized with PLP 
139–151. The cells were 
stimulated with PLP 139–
151 and proliferation was 
measured as above. Mean 
± SEM values are shown. (n 
= males, 8; females, 7). (1.5 
μg/ml, p ≤ 0.08; 15 μg/ml, 
p ≤ 0.09). 
Figure 3. Depletion of Treg cells before immunization with PLP 139– 
151 enhances Ag-specific T cell proliferation and inflammatory cy-
tokines in male B10.S mice. a, Male B10.S mice pretreated with anti-
CD25 or isotype control on day -5 and day -3 were immunized with 
PLP 139–151. Ten days later, CD3+ cells were stimulated with PLP 
139–151 and proliferation was measured as described in Materials and 
Methods. A representative experiment is shown. b, Viable lympho-
blasts harvested from the cultures stimulated with PLP 139–151 were 
stained with PLP 139–151 or TMEV 70–86 tetramers. Mean ± SEM val-
ues are shown (n = day 4, 6; day 6, 10). ( *,p ≤ 0.02; **, p≤ 0.01). c, Cy-
tokine ELISA: supernatants from cultures stimulated with PLP 139–
151 were examined for cytokine secretion by ELISA and compared 
between groups (n = 8–12 mice/group) (IL-2, p ≤ 0.01; IL-10, p ≤ 0.02; 
IFN-γ, p ≤ 0.006, and IL-17, p ≤ 0.08). Intracellular staining: viable lym-
phoblasts were harvested on day 4 from the cultures described above 
and restimulated with anti-TCR β and anti-CD28 Ab for 4–6 h and 
stained with anti-CD4 and 7-AAD. The frequency of cytokine-secret-
ing cells was then determined by flow cytometry in the live (7-AAD-) 
CD4+ subset. Each bar represents mean ± SEM values (n = rat IgG, 9; 
n = anti-CD25, 10). (IL-2 and IL-10, p ≤ 0.01; IL-4, p ≤ 0.0005; IFN-≤, p ≤ 
0.02; IL-6, p ≤ 0.001; and IL-17, p ≤ 0.056). 
t R e g  C e l l s  C o n t R i b u t e  t o  g e n d e R  d i f f e R e n C e s  i n  eae   5595
We then sought to detect any fundamental difference in the 
expansion of effector cells between male and female B10.S wt 
mice. Using anti-CD3 as a stimulus, we observed that the effec-
tor cells from male B10.S mice expanded to a greater extent than 
those from female mice (Figure 4a). To verify that a similar differ-
ential response occurs to PLP 139–151, we immunized groups of 
male and female B10.S mice with PLP 139–151 after treating them 
with anti-CD25 or control Ab. We measured the PLP 139–151-spe-
cific response by [3H]thymidine incorporation. As expected, mice 
depleted of CD25+ cells responded to PLP 139–151 significantly 
more strongly than controls of either sex (Figure 4b). However, 
the T cell response to PLP 139– 151 in the male B10.S mice tended 
to be higher than in the female mice treated with anti-CD25 Ab, 
especially at lower Ag concentrations (Figure 4b). Similar trends 
were confirmed by using 5B6 tg T cells specific to PLP 139–151 
(data not shown). These data suggest that the autoreactive effector 
cells in male B10.S mice can respond to autoantigens vigorously, 
but they are kept in check by Treg cells. 
In summary, in male B10.S mice treated with anti-CD25 Ab, 
the incidence of PLP 139–151-induced EAE was enhanced signif-
icantly when compared with female B10.S mice, suggesting that 
Treg cells do not play as large of a role in mediating genetic resis-
tance to EAE in female compared with male mice. Although there 
was no fundamental difference in Treg cell function between male 
and female mice, the effector cells from male B10.S mice in the ab-
sence of Treg cells tended to proliferate to a higher degree than 
those from females. This suggests that male Treg cells control the 
expansion of pathogenic autoreactive cells more effectively and 
that this contributes to their greater disease resistance.  
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